When venture capital barely existed in Germany, Professor Detlev Riesner saw a chance to turn pure science into a business that would reshape global biotech. As co-founder and later chair of Qiagen, …
Listen to this episode with a 7-day free trial
Subscribe to Startuprad.io’s Newsletter to listen to this post and get 7 days of free access to the full post archives.
